Multiple myeloma results from the degeneration of a single plasma cell whose clones spread throughout the bone marrow. Overall, the disease occurs very rarely. However, it is one of the most common tumors of bone and bone marrow. Intensive research is being conducted into the non-Hodgkin’s lymphoma group in order to improve the prognosis of those affected in the long term.
Autoren
- Leoni Burggraf
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Stroke
With polypills and co. against stroke and its consequences
- Post-COVID
Complaints from a neurological point of view
- Obstructive sleep apnea syndrome
Fitness to drive with OSAS
- Smoking cessation
On the way to better health – alternative nicotine products in view
- Age-related cognitive impairments
Ginkgo biloba extracts bring benefits
- Casuistry
SLE with kidney damage does not always have to be lupus nephritis
- Viral hepatitis
Hepatitis ABC(EN): Prophylaxis and treatment – an update
- Type 2 diabetes: reduction of microvascular and macrovascular risks